Stage 2 infant formula is a specialized formula designed for infants aged 6-12 months. It differs from Stage 1 formula in its nutritional composition to meet the evolving nutritional needs of growing infants. Stage 2 formula typically contains higher levels of iron and zinc to support cognitive and immune development. Additionally, it may also contain probiotics and prebiotics to promote gut health.
The global Stage 2 Infant Formula market size is projected to grow from US$ 20030 million in 2024 to US$ 29980 million in 2030; it is expected to grow at a CAGR of 7.0% from 2024 to 2030.
The 鈥淪tage 2 Infant Formula Industry Forecast鈥� looks at past sales and reviews total world Stage 2 Infant Formula sales in 2023, providing a comprehensive analysis by region and market sector of projected Stage 2 Infant Formula sales for 2024 through 2030. With Stage 2 Infant Formula sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Stage 2 Infant Formula industry.
This Insight Report provides a comprehensive analysis of the global Stage 2 Infant Formula landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Stage 2 Infant Formula portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Stage 2 Infant Formula market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Stage 2 Infant Formula and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Stage 2 Infant Formula.
United States market for Stage 2 Infant Formula is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Stage 2 Infant Formula is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Stage 2 Infant Formula is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Stage 2 Infant Formula players cover Mead Johnson, Nestle, Danone, Abbott, FrieslandCampina, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Stage 2 Infant Formula market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Conventional
Organic
Segmentation by Application:
Online Sales
Offline Sales
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Mead Johnson
Nestle
Danone
Abbott
FrieslandCampina
Heinz
Bellamy
Topfer
HiPP
Perrigo
Arla
Holle
Meiji
Biostime
China Feihe
Junlebao Dairy
Ausnutria Dairy
Yili Group
Synutra
Beingmate
Yashili
Bright Dairy
Key Questions Addressed in this Report
What is the 10-year outlook for the global Stage 2 Infant Formula market?
What factors are driving Stage 2 Infant Formula market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Stage 2 Infant Formula market opportunities vary by end market size?
How does Stage 2 Infant Formula break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Stage 2 Infant Formula Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Stage 2 Infant Formula by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Stage 2 Infant Formula by Country/Region, 2019, 2023 & 2030
2.2 Stage 2 Infant Formula Segment by Type
2.2.1 Conventional
2.2.2 Organic
2.3 Stage 2 Infant Formula Sales by Type
2.3.1 Global Stage 2 Infant Formula Sales Market Share by Type (2019-2024)
2.3.2 Global Stage 2 Infant Formula Revenue and Market Share by Type (2019-2024)
2.3.3 Global Stage 2 Infant Formula Sale Price by Type (2019-2024)
2.4 Stage 2 Infant Formula Segment by Application
2.4.1 Online Sales
2.4.2 Offline Sales
2.5 Stage 2 Infant Formula Sales by Application
2.5.1 Global Stage 2 Infant Formula Sale Market Share by Application (2019-2024)
2.5.2 Global Stage 2 Infant Formula Revenue and Market Share by Application (2019-2024)
2.5.3 Global Stage 2 Infant Formula Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Stage 2 Infant Formula Breakdown Data by Company
3.1.1 Global Stage 2 Infant Formula Annual Sales by Company (2019-2024)
3.1.2 Global Stage 2 Infant Formula Sales Market Share by Company (2019-2024)
3.2 Global Stage 2 Infant Formula Annual Revenue by Company (2019-2024)
3.2.1 Global Stage 2 Infant Formula Revenue by Company (2019-2024)
3.2.2 Global Stage 2 Infant Formula Revenue Market Share by Company (2019-2024)
3.3 Global Stage 2 Infant Formula Sale Price by Company
3.4 Key Manufacturers Stage 2 Infant Formula Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Stage 2 Infant Formula Product Location Distribution
3.4.2 Players Stage 2 Infant Formula Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Stage 2 Infant Formula by Geographic Region
4.1 World Historic Stage 2 Infant Formula Market Size by Geographic Region (2019-2024)
4.1.1 Global Stage 2 Infant Formula Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Stage 2 Infant Formula Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Stage 2 Infant Formula Market Size by Country/Region (2019-2024)
4.2.1 Global Stage 2 Infant Formula Annual Sales by Country/Region (2019-2024)
4.2.2 Global Stage 2 Infant Formula Annual Revenue by Country/Region (2019-2024)
4.3 Americas Stage 2 Infant Formula Sales Growth
4.4 APAC Stage 2 Infant Formula Sales Growth
4.5 Europe Stage 2 Infant Formula Sales Growth
4.6 Middle East & Africa Stage 2 Infant Formula Sales Growth
5 Americas
5.1 Americas Stage 2 Infant Formula Sales by Country
5.1.1 Americas Stage 2 Infant Formula Sales by Country (2019-2024)
5.1.2 Americas Stage 2 Infant Formula Revenue by Country (2019-2024)
5.2 Americas Stage 2 Infant Formula Sales by Type (2019-2024)
5.3 Americas Stage 2 Infant Formula Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Stage 2 Infant Formula Sales by Region
6.1.1 APAC Stage 2 Infant Formula Sales by Region (2019-2024)
6.1.2 APAC Stage 2 Infant Formula Revenue by Region (2019-2024)
6.2 APAC Stage 2 Infant Formula Sales by Type (2019-2024)
6.3 APAC Stage 2 Infant Formula Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Stage 2 Infant Formula by Country
7.1.1 Europe Stage 2 Infant Formula Sales by Country (2019-2024)
7.1.2 Europe Stage 2 Infant Formula Revenue by Country (2019-2024)
7.2 Europe Stage 2 Infant Formula Sales by Type (2019-2024)
7.3 Europe Stage 2 Infant Formula Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Stage 2 Infant Formula by Country
8.1.1 Middle East & Africa Stage 2 Infant Formula Sales by Country (2019-2024)
8.1.2 Middle East & Africa Stage 2 Infant Formula Revenue by Country (2019-2024)
8.2 Middle East & Africa Stage 2 Infant Formula Sales by Type (2019-2024)
8.3 Middle East & Africa Stage 2 Infant Formula Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Stage 2 Infant Formula
10.3 Manufacturing Process Analysis of Stage 2 Infant Formula
10.4 Industry Chain Structure of Stage 2 Infant Formula
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Stage 2 Infant Formula Distributors
11.3 Stage 2 Infant Formula Customer
12 World Forecast Review for Stage 2 Infant Formula by Geographic Region
12.1 Global Stage 2 Infant Formula Market Size Forecast by Region
12.1.1 Global Stage 2 Infant Formula Forecast by Region (2025-2030)
12.1.2 Global Stage 2 Infant Formula Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Stage 2 Infant Formula Forecast by Type (2025-2030)
12.7 Global Stage 2 Infant Formula Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Mead Johnson
13.1.1 Mead Johnson Company Information
13.1.2 Mead Johnson Stage 2 Infant Formula Product Portfolios and Specifications
13.1.3 Mead Johnson Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Mead Johnson Main Business Overview
13.1.5 Mead Johnson Latest Developments
13.2 Nestle
13.2.1 Nestle Company Information
13.2.2 Nestle Stage 2 Infant Formula Product Portfolios and Specifications
13.2.3 Nestle Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Nestle Main Business Overview
13.2.5 Nestle Latest Developments
13.3 Danone
13.3.1 Danone Company Information
13.3.2 Danone Stage 2 Infant Formula Product Portfolios and Specifications
13.3.3 Danone Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Danone Main Business Overview
13.3.5 Danone Latest Developments
13.4 Abbott
13.4.1 Abbott Company Information
13.4.2 Abbott Stage 2 Infant Formula Product Portfolios and Specifications
13.4.3 Abbott Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Abbott Main Business Overview
13.4.5 Abbott Latest Developments
13.5 FrieslandCampina
13.5.1 FrieslandCampina Company Information
13.5.2 FrieslandCampina Stage 2 Infant Formula Product Portfolios and Specifications
13.5.3 FrieslandCampina Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 FrieslandCampina Main Business Overview
13.5.5 FrieslandCampina Latest Developments
13.6 Heinz
13.6.1 Heinz Company Information
13.6.2 Heinz Stage 2 Infant Formula Product Portfolios and Specifications
13.6.3 Heinz Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Heinz Main Business Overview
13.6.5 Heinz Latest Developments
13.7 Bellamy
13.7.1 Bellamy Company Information
13.7.2 Bellamy Stage 2 Infant Formula Product Portfolios and Specifications
13.7.3 Bellamy Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Bellamy Main Business Overview
13.7.5 Bellamy Latest Developments
13.8 Topfer
13.8.1 Topfer Company Information
13.8.2 Topfer Stage 2 Infant Formula Product Portfolios and Specifications
13.8.3 Topfer Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Topfer Main Business Overview
13.8.5 Topfer Latest Developments
13.9 HiPP
13.9.1 HiPP Company Information
13.9.2 HiPP Stage 2 Infant Formula Product Portfolios and Specifications
13.9.3 HiPP Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 HiPP Main Business Overview
13.9.5 HiPP Latest Developments
13.10 Perrigo
13.10.1 Perrigo Company Information
13.10.2 Perrigo Stage 2 Infant Formula Product Portfolios and Specifications
13.10.3 Perrigo Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Perrigo Main Business Overview
13.10.5 Perrigo Latest Developments
13.11 Arla
13.11.1 Arla Company Information
13.11.2 Arla Stage 2 Infant Formula Product Portfolios and Specifications
13.11.3 Arla Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Arla Main Business Overview
13.11.5 Arla Latest Developments
13.12 Holle
13.12.1 Holle Company Information
13.12.2 Holle Stage 2 Infant Formula Product Portfolios and Specifications
13.12.3 Holle Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Holle Main Business Overview
13.12.5 Holle Latest Developments
13.13 Meiji
13.13.1 Meiji Company Information
13.13.2 Meiji Stage 2 Infant Formula Product Portfolios and Specifications
13.13.3 Meiji Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Meiji Main Business Overview
13.13.5 Meiji Latest Developments
13.14 Biostime
13.14.1 Biostime Company Information
13.14.2 Biostime Stage 2 Infant Formula Product Portfolios and Specifications
13.14.3 Biostime Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Biostime Main Business Overview
13.14.5 Biostime Latest Developments
13.15 China Feihe
13.15.1 China Feihe Company Information
13.15.2 China Feihe Stage 2 Infant Formula Product Portfolios and Specifications
13.15.3 China Feihe Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 China Feihe Main Business Overview
13.15.5 China Feihe Latest Developments
13.16 Junlebao Dairy
13.16.1 Junlebao Dairy Company Information
13.16.2 Junlebao Dairy Stage 2 Infant Formula Product Portfolios and Specifications
13.16.3 Junlebao Dairy Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Junlebao Dairy Main Business Overview
13.16.5 Junlebao Dairy Latest Developments
13.17 Ausnutria Dairy
13.17.1 Ausnutria Dairy Company Information
13.17.2 Ausnutria Dairy Stage 2 Infant Formula Product Portfolios and Specifications
13.17.3 Ausnutria Dairy Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Ausnutria Dairy Main Business Overview
13.17.5 Ausnutria Dairy Latest Developments
13.18 Yili Group
13.18.1 Yili Group Company Information
13.18.2 Yili Group Stage 2 Infant Formula Product Portfolios and Specifications
13.18.3 Yili Group Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Yili Group Main Business Overview
13.18.5 Yili Group Latest Developments
13.19 Synutra
13.19.1 Synutra Company Information
13.19.2 Synutra Stage 2 Infant Formula Product Portfolios and Specifications
13.19.3 Synutra Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Synutra Main Business Overview
13.19.5 Synutra Latest Developments
13.20 Beingmate
13.20.1 Beingmate Company Information
13.20.2 Beingmate Stage 2 Infant Formula Product Portfolios and Specifications
13.20.3 Beingmate Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Beingmate Main Business Overview
13.20.5 Beingmate Latest Developments
13.21 Yashili
13.21.1 Yashili Company Information
13.21.2 Yashili Stage 2 Infant Formula Product Portfolios and Specifications
13.21.3 Yashili Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 Yashili Main Business Overview
13.21.5 Yashili Latest Developments
13.22 Bright Dairy
13.22.1 Bright Dairy Company Information
13.22.2 Bright Dairy Stage 2 Infant Formula Product Portfolios and Specifications
13.22.3 Bright Dairy Stage 2 Infant Formula Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Bright Dairy Main Business Overview
13.22.5 Bright Dairy Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.